(Q68888659)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

S K Gregorian

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J R Battisto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

325-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity

28 September 2019

cites work

1 reference

12 December 2020

Lymphokine-activated killer cells: a new approach to immunotherapy of cancer

1 reference

12 December 2020

Successful treatment of advanced murine renal cell cancer by bicompartmental adoptive chemoimmunotherapy

1 reference

12 December 2020

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

1 reference

12 December 2020

A murine renal cell carcinoma

1 reference

12 December 2020

Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages

1 reference

12 December 2020

Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.

1 reference

12 December 2020

Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.

1 reference

12 December 2020

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

12 December 2020

Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes.

1 reference

12 December 2020

Changes in splenic macrophage Mac antigen expression during tumor growth: a kinetic study of accessory cell function and antigen-defined phenotypes

1 reference

12 December 2020

THE ROLE OF THE T ACCEPTOR CELL IN SUPPRESSOR SYSTEMS: Antigen-Specific T Suppressor Factor Acts via a T Acceptor Cell; This Releases a Nonspecific Inhibitor of the Transfer of Contact Sensitivity When Exposed to Antigen in the Context of I-J

1 reference

12 December 2020

Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice

1 reference

12 December 2020

Immunotherapy of a murine renal cancer

1 reference

12 December 2020

Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity

1 reference

12 December 2020

Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance

1 reference

12 December 2020

Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients

1 reference

12 December 2020

Immunosuppression and the Role of Suppressive Factors in Cancer

1 reference

12 December 2020

The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells

1 reference

12 December 2020

In vitro and in vivo antitumor activity of lymphokine-induced cytotoxic cells

1 reference

12 December 2020

Immunoregulatory factors derived from human tumors. I. Immunologic and biochemical characterization of factors that suppress lymphocyte proliferative and cytotoxic responses in vitro

1 reference

12 December 2020

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

12 December 2020

Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function

1 reference

12 December 2020

Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors

1 reference

12 December 2020

Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma

1 reference

12 December 2020

Human lymphokine-activated killer cells (LAK cells) as a potential immunotherapeutic modality

1 reference

12 December 2020

Changes in macrophage populations: phenotypic differences between normal and tumor-bearing host macrophages

1 reference

12 December 2020

Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro

1 reference

12 December 2020

Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.

1 reference

12 December 2020

Validation of the tumor, nodes and metastasis classification of renal cell carcinoma.

1 reference

12 December 2020

Suppressor mechanisms in tumor immunity

1 reference

12 December 2020

Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells

1 reference

12 December 2020

Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells

1 reference

12 December 2020

Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer

1 reference

12 December 2020

An inhibitor of lymphocyte proliferation produced by a human colonic adenocarcinoma cell line in culture

1 reference

12 December 2020

Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity

1 reference

12 December 2020

Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.

1 reference

12 December 2020

Inhibition of normal allogenic lymphocyte mitogenesis by a soluble inhibitor extracted from human colonic carcinoma.

1 reference

12 December 2020

Role of natural killer activity in development of spontaneous metastases in murine renal cancer.

1 reference

12 December 2020

Modification of host antitumor defense mechanisms in mice by progressively growing tumor

1 reference

12 December 2020

Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity

1 reference

12 December 2020

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

1 reference

12 December 2020

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

12 December 2020

Suppression of contact sensitivity and cell-mediated lympholysis by oral administration of hapten is caused by different mechanisms

1 reference

12 December 2020

Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens

1 reference

12 December 2020

Investigation of a new renal tumor model

1 reference

12 December 2020

Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression

1 reference

12 December 2020

Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression

1 reference

12 December 2020

Generation of activated killer cells in tumor-bearing hosts

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01741403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2386978%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference